IXICO has announced it has signed a contract with the Global Alzheimer’s Platform (GAP) Foundation to support the foundation’s Bio-Hermes-2 trial. The contract is worth over £1m over a 48-month period; however, we believe the value to IXICO will be greater than this ‘headline’ amount due to the increased visibility and wider recognition of the company’s technology within the Alzheimer’s disease clinical development community. IXICO participated and presented data from the initial Bio-Hermes tria ....
23 May 2024
IXICO - Alzheimer’s contract win
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
IXICO - Alzheimer’s contract win
IXICO Plc (IXI:LON) | 9.0 0 0.0% | Mkt Cap: 4.35m
- Published:
23 May 2024 -
Author:
Chris Donnellan -
Pages:
5
IXICO has announced it has signed a contract with the Global Alzheimer’s Platform (GAP) Foundation to support the foundation’s Bio-Hermes-2 trial. The contract is worth over £1m over a 48-month period; however, we believe the value to IXICO will be greater than this ‘headline’ amount due to the increased visibility and wider recognition of the company’s technology within the Alzheimer’s disease clinical development community. IXICO participated and presented data from the initial Bio-Hermes tria ....